Home › Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform
 

Keywords :   


Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform

2015-02-23 11:30:53| Industrial Newsroom - All News for Today

Genedata Biologics integrates and streamlines workflows for protein therapeutics RD groups across multiple Boehringer Ingelheim sites Basel, Switzerland  Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Boehringer Ingelheim has chosen...

Tags: platform discovery antibody workflow

Category:Industrial Goods and Services

Latest from this category

All news
»
15.11171
15.11 3FLYOVER
15.11 PSA8 - 1ed
15.11DMC RAVEN 18g
15.11LOVE or DEAD Blu-ray
15.11 HSGI SURE-GRIP PADDED BELT a-tacs au
15.11 BOUNTY HUNTER
15.11
More »